← Search recalls
FDA (Drug enforcement)Recalled 2023-07-17closedclass ii

Central Admixture Pharmacy Services Inc: fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, S

Hazard

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Details from the source

Reason for recall: Lack of assurance of sterility: Lack of validation data for sanitization cycles Distribution: Nationwide in the USA Quantity: 2,082 syringes Lot/code info: Lot: 17-271133, 17-271155, Exp. 7/25/2023; 17-271568, 17-271569, Exp. 8/1/2023; 17-271741, 17-271762, Exp. 8/3/2023; 17-272051, Exp. 8/9/2023; 17-272227, Exp. 8/13/2023; 17-272343, Exp. 8/15/2023; 17-272799, Exp. 8/22/2023; 17-273173, Exp. 8/29/2023; 17-273495, Exp. 9/4/2023.

Source

Official record: FDA (Drug enforcement)

Republished from the official source above; details can change — the source record controls.

Hurt by this product? Start a free Case Check

ProductRisk is not a law firm and does not provide legal services or legal advice. ProductRisk is a free consumer product-safety information service operated by Plaintify, Inc., a technology company. If you ask to be connected with a law firm, any legal services are provided by that firm — not by ProductRisk or Plaintify.

Privacy · Plaintify